Omega Healthcare Investors (NYSE:OHI) Earns Neutral Rating from Analysts at Citigroup

Share on StockTwits

Equities researchers at Citigroup started coverage on shares of Omega Healthcare Investors (NYSE:OHI) in a research note issued on Wednesday, MarketBeat.com reports. The firm set a “neutral” rating and a $44.00 price target on the real estate investment trust’s stock. Citigroup‘s price objective suggests a potential upside of 1.78% from the company’s previous close.

Several other research analysts also recently commented on the stock. Mizuho began coverage on shares of Omega Healthcare Investors in a research note on Thursday, December 19th. They set a “buy” rating and a $50.00 price target on the stock. Bank of America reissued a “buy” rating and set a $44.50 price target on shares of Omega Healthcare Investors in a research note on Monday, October 14th. Wells Fargo & Co reissued a “hold” rating on shares of Omega Healthcare Investors in a research note on Monday, December 9th. Zacks Investment Research downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Wednesday, January 8th. Finally, Raymond James downgraded shares of Omega Healthcare Investors from a “strong-buy” rating to a “market perform” rating in a research note on Monday, October 21st. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. Omega Healthcare Investors presently has an average rating of “Hold” and a consensus target price of $43.32.

OHI stock opened at $43.23 on Wednesday. The company has a market capitalization of $9.62 billion, a PE ratio of 26.69, a price-to-earnings-growth ratio of 5.53 and a beta of 0.31. Omega Healthcare Investors has a one year low of $34.64 and a one year high of $45.01. The company’s 50 day moving average price is $42.19 and its two-hundred day moving average price is $40.96. The company has a debt-to-equity ratio of 1.13, a quick ratio of 3.00 and a current ratio of 3.00.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.63 EPS for the quarter, missing the consensus estimate of $0.73 by ($0.10). The business had revenue of $199.00 million for the quarter, compared to analysts’ expectations of $194.26 million. Omega Healthcare Investors had a return on equity of 8.76% and a net margin of 38.12%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same period last year, the business posted $0.77 earnings per share. On average, research analysts predict that Omega Healthcare Investors will post 2.99 EPS for the current year.

In related news, insider Steven J. Insoft sold 50,000 shares of Omega Healthcare Investors stock in a transaction on Monday, January 6th. The shares were sold at an average price of $42.12, for a total value of $2,106,000.00. Following the transaction, the insider now directly owns 258,032 shares of the company’s stock, valued at $10,868,307.84. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.16% of the stock is owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. FTB Advisors Inc. increased its stake in shares of Omega Healthcare Investors by 48.4% in the fourth quarter. FTB Advisors Inc. now owns 766 shares of the real estate investment trust’s stock worth $32,000 after buying an additional 250 shares during the period. We Are One Seven LLC increased its stake in shares of Omega Healthcare Investors by 3.6% in the third quarter. We Are One Seven LLC now owns 10,320 shares of the real estate investment trust’s stock worth $431,000 after buying an additional 360 shares during the period. NEXT Financial Group Inc increased its stake in shares of Omega Healthcare Investors by 5.0% in the third quarter. NEXT Financial Group Inc now owns 8,328 shares of the real estate investment trust’s stock worth $348,000 after buying an additional 397 shares during the period. 6 Meridian increased its stake in shares of Omega Healthcare Investors by 3.0% in the fourth quarter. 6 Meridian now owns 14,904 shares of the real estate investment trust’s stock worth $631,000 after buying an additional 429 shares during the period. Finally, Pacific Wealth Strategies Group Inc. increased its stake in shares of Omega Healthcare Investors by 5.3% in the fourth quarter. Pacific Wealth Strategies Group Inc. now owns 8,585 shares of the real estate investment trust’s stock worth $364,000 after buying an additional 434 shares during the period. 75.28% of the stock is currently owned by institutional investors.

About Omega Healthcare Investors

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Featured Article: Why does a company issue an IPO?

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Insider Selling: Pinterest  General Counsel Sells $579,000.00 in Stock
Insider Selling: Pinterest General Counsel Sells $579,000.00 in Stock
Scott A. Musil Sells 13,966 Shares of First Industrial Realty Trust, Inc.  Stock
Scott A. Musil Sells 13,966 Shares of First Industrial Realty Trust, Inc. Stock
Insider Selling: PetIQ Inc  EVP Sells $602,175.00 in Stock
Insider Selling: PetIQ Inc EVP Sells $602,175.00 in Stock
Snap Inc  Director Sells $460,080.00 in Stock
Snap Inc Director Sells $460,080.00 in Stock
Ra Pharmaceuticals Inc  Insider Sells $493,832.95 in Stock
Ra Pharmaceuticals Inc Insider Sells $493,832.95 in Stock
Insider Selling: Axcelis Technologies Inc  VP Sells 19,500 Shares of Stock
Insider Selling: Axcelis Technologies Inc VP Sells 19,500 Shares of Stock


 
© 2006-2020 Zolmax.